Ignite Creation Date:
2025-12-24 @ 11:20 PM
Ignite Modification Date:
2025-12-25 @ 9:03 PM
Study NCT ID:
NCT05987956
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-06-06
First Post:
2023-07-29
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Pharmacogenomics IND EXEMPT SNP Clinical Study - Alectinib and Single Nucleotide Polymorphisms
Sponsor:
Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-11-08
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-11-18
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-12-28
Completion Date Type:
ESTIMATED
First Submit Date:
2023-07-29
First Submit QC Date:
None
Study First Post Date:
2023-08-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-04
Last Update Post Date:
2025-06-06
Last Update Post Date Type:
ACTUAL